AAZIM PHARMACEUTICS LIMITED
Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-08-31 | 2024-08-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (15 events)Click to expand
- 2025-10-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-10-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-01-06📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2020-12-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-11-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-08-22📄change-person-director-company-with-change-dateofficers · CH01
- 2019-08-20📄change-person-director-company-with-change-dateofficers · CH01
- 2019-08-20📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2019-01-24📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-09-10📄resolutionresolution · RESOLUTIONS
- 2018-08-20🏢Company incorporatedAs AAZIM PHARMACEUTICS LIMITED
- 2018-08-20➕IMRAN, Mohammed Aazim appointeddirector
- 2018-08-20📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Mohammed Aazim Imran Individual · British · DOB 10/1994 · age 32 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 20/08/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 2020 VISION LIMITED→ 16267111 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| A AND E LOCUM SERVICES LIMITED→ 11145422 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| A.A CARE LTD→ 13385369 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AA PHYSIO LIMITED→ 15720070 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AAMANAH CARE GROUP LTD→ 16643097 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AAMANAH CARE SERVICES LTD→ 16946633 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AAMAT LTD→ 12963200 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AAMINA LTD→ 16008107 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ABM MEDICARE LTD→ 14615879 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ABO CONSULTANCY LIMITED→ 08966827 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ABSAMC (UK) LTD→ 08649717 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| ABU ZAHRA CARERS LIMITED→ 07923568 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.